ccc EU cautioned not to use animal organs | Antidote Europe

More Press Releases

Patients are now the real guinea pigs

Antidote Europe welcomes recent French media reports warning the public about dangerous medicines.

BBC presenter Uhlenbroek joins scientists on campaign

The campaign’s report presents an immediate science strategy to end poisoning tests on non-human primates.

Making a molehill out of the Bisphenol A mountain

Antidote Europe has criticised the French government for taking very timid measures to ban the synthetic chemical bisphenol A (BPA). It makes no sense to protect nursing infants by banning the substance in baby bottles when their mothers are exposed to it on a daily basis — not to mention the effect on the foetuses of pregnant women.

Another warning about bisphenol A

Antidote Europe has re-issued its warning on bisphenol A, criticizing the French Food Safety Agency (AFSSA) on its confused and unclear public announcements regarding this chemical.

Antidote Europe receives achievement award

Antidote Europe was awarded the Pietro Croce prize.

Is Bisphenol A the new silent killer?

Antidote Europe has launched a public campaign regarding the dangers of bisphenol A and has duly informed the new president of the European Parliament.

Bisphenol A, a chemical time bomb?

It is difficult to understand why food safety agencies continue to place their trust in ambiguous animal data when human data is readily available. The fact that DES and BPA share striking similarities in their structures is extremely worrisome and lends weight to the possibility that BPA is a “chemical time bomb” in terms of our health.

EU directive lags woefully behind the science

With a crucial vote about to take place on Tuesday 31st March, by the Agriculture Committee (AGRI) of the European Parliament, Antidote Europe has written to all members of this committee, urging them to include a clause in the revised version of the 86/609 directive, to facilitate the adoption of any scientifically sound, non animal method, based on the “weight of evidence” principle. Such a clause would significantly increase the scope and application of non animal methods in practice.

EU continues to allow bisphenol in baby dummies

According to EFSA, the exposure of the human foetus to bisphenol A would be negligible because the mother rapidly metabolizes and eliminates this substance from her body. This conclusion is in contradiction with basic pharmacokinetics knowledge.

Authorities warned of Bisphenol A health risk

The results of our analysis of bisphenol A using toxicogenomics techniques have been conveyed to the French and European agencies for food safety and to Canadian Health Authorities.


Press Releases

Public health group cautions EU not to use animal organs



Tue 17 Jun 2008



Antidote Europe has issued an urgent caution against the idea of transplanting animal organs into people.

The public health advocacy group Antidote Europe issued an urgent caution today against the idea of transplanting animal organs into people. An announcement released on 16 June in the scientific journal Kidney International by a team of Belgian researchers suggests that genetically altered pig organs could soon be transplanted into people, stating: “Today we are on the threshold of the first clinical trials.”

Antidote Europe has contacted the Belgian Minister of Health and the EU commissioner for public safety, Stavros Dimas, to warn them of the dangers to public health of embarking on such an experiment. Says Antidote Director Dr Andre Menache, “At a time when government authorities are concerned about the transmission to people of diseases such as bird flu, how can they justify the idea of transplanting animal organs? In addition to the risk of transmitting unknown viruses, the basic problems of rejection still exist. Rather than solving health issues, this will create dangerous new ones.”


“Xenotransplantation: Where are we in 2008?” B. Sprangers, M. Waer & A. D. Billiau. Kidney Int, 2008 74: 14-21 (advance online publication, April 16, 2008; 10.1038/ki.2008.135).